James M. Acton, Ankit Panda
{
"authors": [
"James M. Acton"
],
"type": "legacyinthemedia",
"centerAffiliationAll": "dc",
"centers": [
"Carnegie Endowment for International Peace"
],
"collections": [],
"englishNewsletterAll": "ctw",
"nonEnglishNewsletterAll": "",
"primaryCenter": "Carnegie Endowment for International Peace",
"programAffiliation": "NPP",
"programs": [
"Nuclear Policy"
],
"projects": [],
"regions": [
"Middle East",
"Iran"
],
"topics": [
"Nuclear Policy",
"Nuclear Energy"
]
}Source: Getty
U.S. Should Call Iran's Bluff
While it remains unclear whether Iran’s President Mahmoud Ahmadinejad is sincere in his proposal to cease production of highly enriched nuclear fuel and import it instead, it is clearly in the West’s best interests to accept the offer.
Source: Los Angeles Times

About the Author
Jessica T. Mathews Chair, Co-director, Nuclear Policy Program
Acton holds the Jessica T. Mathews Chair and is co-director of the Nuclear Policy Program at the Carnegie Endowment for International Peace.
- Nuclear Weapons and the Future of American PowerPaper
- The Latest Iran Deal Ignores the Lessons of the PastCommentary
James M. Acton
Recent Work
Carnegie India does not take institutional positions on public policy issues; the views represented herein are those of the author(s) and do not necessarily reflect the views of Carnegie, its staff, or its trustees.
More Work from Carnegie India
- Risk and Retaliation: Israel, Iran, and the Evolving Situation in West AsiaArticle
An Israeli response to Iran’s October 1 attack is imminent. The key question is of its intensity and potential fallout, both within Iran, in terms of nuclear security policy changes, and across the broader region. The coming days are likely to reshape West Asia irreversibly.
Gaddam Dharmendra
- How WHO’s “One Health” Program Can Help India Tackle MonkeypoxCommentary
With monkeypox being declared a global health emergency, the WHO approach is an innovative and effective way to curb outbreaks of zoonotic diseases.
Shruti Sharma
- Lessons from the Coronavirus Pandemic: Leveraging Biotechnology to Tackle Infectious Diseases in IndiaPaper
In India, biotechnology has played an important role in helping stakeholders in academia, industry, and government develop new pandemic-related technology, from test kits to respiratory devices. But these biotechnology advancements can go further to strengthen India’s public health capacity.
Shruti Sharma
- Combating Vaccine Hesitancy in IndiaCommentary
Unless the government can up its communications game, anti-vax movements could prolong India’s pandemic effects.
Shruti Sharma
- How Should Countries Study Viruses Safely?Commentary
The uncertain origin of the coronavirus has focused attention on gain-of-function research—studying viruses to learn how they spread. How can countries work together to ensure stringent safety standards?
Shruti Sharma